Pfizer BioNTech's approved by US regulators, ships to resume berthing at Ningbo, the outlook for cryptocurrencies, Visa and crypto punk, Chinese regulator halts 42 IPOs on probe of broker, SEC's updated requirements for US IPO Disclosures, Dividends for this year, DIDI, Microsoft, Chinese tech and HSI

Pfizer BioNTech's approved by US regulators, ships to resume berthing at Ningbo, the outlook for cryptocurrencies, Visa and crypto punk, Chinese regulator halts 42 IPOs on probe of broker, SEC's updated requirements for US IPO Disclosures, Dividends for this year, DIDI, Microsoft, Chinese tech and HSI

What has the impact of the US approval of the Pfizer BioNTech rally on markets? Which companies are mandating vaccinations? What has been the market reaction to the resumption of ships berthing at the Chinese port of Ningbo? And is the NFT craze hitting up again?What does this mean for Ether the currency you buy NFT’s with?

Michelle Martin and Ryan Huang go beyond the headlines and buzz in this edition of Market View.

See omnystudio.com/listener for privacy information.

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
psykopodiaa-podcast
rss-rahapodi
pomojen-suusta
ostan-asuntoja-podcast
rss-rahamania
rahapuhetta
rss-myyntikoulu
rss-draivi
herrasmieshakkerit
juristipodi
salkunrakentaja-podi
sijoitusovi-podcast
rss-h-asselmoilanen
rss-lahtijat
rss-startup-ministerio
rss-seuraava-potilas
rss-set-for-life-sijoita-ja-vaurastu
rss-viisas-raha-podi